HemaSphere (Jun 2022)
P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.
- J. Xavier-Ferrucio,
- C. Luo,
- G. Angelini,
- S. Krishnamurthy,
- N. Patel,
- M. Pettiglio,
- T. Collingsworth,
- M. Isik,
- A. Ghodssi,
- A. Halfond,
- J. Etchin,
- Y. Keschner,
- G. Mundelboim,
- P. Tavares,
- C. Cummins,
- A. Falla,
- D. Hazelbaker,
- E. Paik,
- J. Sanchez,
- G. Ge,
- J. Lydeard,
- M. I. Lin,
- T. Chakraborty
Affiliations
- J. Xavier-Ferrucio
- 1 Vor Biopharma, Cambridge, United States of America
- C. Luo
- 1 Vor Biopharma, Cambridge, United States of America
- G. Angelini
- 1 Vor Biopharma, Cambridge, United States of America
- S. Krishnamurthy
- 1 Vor Biopharma, Cambridge, United States of America
- N. Patel
- 1 Vor Biopharma, Cambridge, United States of America
- M. Pettiglio
- 1 Vor Biopharma, Cambridge, United States of America
- T. Collingsworth
- 1 Vor Biopharma, Cambridge, United States of America
- M. Isik
- 1 Vor Biopharma, Cambridge, United States of America
- A. Ghodssi
- 1 Vor Biopharma, Cambridge, United States of America
- A. Halfond
- 1 Vor Biopharma, Cambridge, United States of America
- J. Etchin
- 1 Vor Biopharma, Cambridge, United States of America
- Y. Keschner
- 1 Vor Biopharma, Cambridge, United States of America
- G. Mundelboim
- 1 Vor Biopharma, Cambridge, United States of America
- P. Tavares
- 1 Vor Biopharma, Cambridge, United States of America
- C. Cummins
- 1 Vor Biopharma, Cambridge, United States of America
- A. Falla
- 1 Vor Biopharma, Cambridge, United States of America
- D. Hazelbaker
- 1 Vor Biopharma, Cambridge, United States of America
- E. Paik
- 1 Vor Biopharma, Cambridge, United States of America
- J. Sanchez
- 1 Vor Biopharma, Cambridge, United States of America
- G. Ge
- 1 Vor Biopharma, Cambridge, United States of America
- J. Lydeard
- 1 Vor Biopharma, Cambridge, United States of America
- M. I. Lin
- 1 Vor Biopharma, Cambridge, United States of America
- T. Chakraborty
- 1 Vor Biopharma, Cambridge, United States of America
- DOI
- https://doi.org/10.1097/01.HS9.0000848572.60330.2f
- Journal volume & issue
-
Vol. 6
pp. 1312 – 1313
Abstract
No abstracts available.